# Neogenomics Inc: Form 8-K, filed Dec 30, 2025

- Company: [Neogenomics Inc](/companies/neo.md) (CIK 1077183)
- Form: 8-K
- Filed: 2025-12-30
- Accepted by EDGAR: Dec 30, 2025, 12:07 ET
- Period: 2025-12-23
- Accession: 0001628280-25-059067
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1077183/000162828025059067/neo-20251223.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1077183/000162828025059067/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1077183/000162828025059067/neo-20251223.htm

Filed Dec 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-059067. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.